Service de Médecine Physique et de Réadaptation et Plateforme 'Mouvement et Handicap', Hôpital Henry Gabrielle, HCL
Saint-Genis-Laval, 69235, France
NCT Number: NCT01565044
Many patients retain upper-limb motor impairment following stroke. Most conventional rehabilitation techniques are aimed to improve motor intentional movement by repeated exercises. These techniques require attentional load and are responsible for significant fatigue that probably represents a limiting factor. Alternatively, the automatic control of action is now well documented. A rehabilitation method based on this principle could allow recovery of more natural movements.
Hypothesis: Stimulating automatic motricity improves upper-limb motor skills compared with a rehabilitation technique based on intentional movements.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Saint-Genis-Laval, 69235, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subject will perform prehension exercises on an automated table. After the initiation of the arm movement, the target to be grasped is programmed to move in order to stimulate automatic motricity.
Time frame: 2 weeks following the last day of the intervention (Day 26)
we are looking for a change in scores between the baseline session score (Day 1), and those collected during this follow-up session (Day 26).
Time frame: immediately following the last day of the intervention (Day 12)
we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session
Time frame: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)
we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session.
Time frame: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)
we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session.
Time frame: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)
we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session
Time frame: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)
we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session.
Time frame: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)
we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session.
Time frame: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)
we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session
Hospices Civils de Lyon
Other
Acronym: AUTOTAB
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03574623
Brain Diseases, Cardiovascular Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT06311526
Brain Diseases, Cardiovascular Diseases
Milan, MI, Italy
View Trial DetailsNCT04241848
Brain Diseases, Cardiovascular Diseases
The Bronx, New York, United States
View Trial DetailsNCT05163210
Brain Diseases, Cardiovascular Diseases
Parma, Emilia-Romagna, Italy
View Trial Details